See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-72. Impact of Gender on Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: Pooled Analysis from the SPIRIT II, III and IV Trials

Presenter: Usman Baber

October 23, 2012

Presentation TCT 2012

Introduction(8)

Presenter: Elizabeth Jackson

October 23, 2012

Presentation TCT 2012

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

TCT-5. Efficacy of Cardiatis Multilayer Flow Modulator in Peripheral and Visceral Aneurysms Repair: Italian Multicenter Registry Results at One Year Follow Up

Presenter: Maria Antonella Ruffino

October 23, 2012

Presentation TCT 2012

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

Presenter: Jonathon Leipsic

October 23, 2012

Presentation TCT 2012

TCT-4. Impact of Catheter Fragmentation Followed by Local Intrapulmonary Thrombolysis in Acute High Risk Pulmonary Embolism as Primary Therapy: Acute and Long Term Outcomes

Presenter: Bishav Garg

October 23, 2012

Presentation TCT 2012

Perspective 1

Presenter: Jeff Davis

October 23, 2012

Presentation TCT 2012

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

Presenter: Joseph Jakubowski

October 23, 2012

Presentation TCT 2012

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from...

Presenter: Ricardo Costa

October 23, 2012

Advertisement

Slides

TCT-72. Impact of Gender on Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: Pooled Analysis from the SPIRIT II, III and IV Trials

Introduction(8)

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

TCT-5. Efficacy of Cardiatis Multilayer Flow Modulator in Peripheral and Visceral Aneurysms Repair: Italian Multicenter Registry Results at One Year Follow Up

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

TCT-4. Impact of Catheter Fragmentation Followed by Local Intrapulmonary Thrombolysis in Acute High Risk Pulmonary Embolism as Primary Therapy: Acute and Long Term Outcomes

Perspective 1

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content